Regulation of the Distribution and Supply of Over-the-Counter and Limited Over-the-Counter Medicines in Modern Retail Outlets under Minister of Health Decree No. 1197/2026
Introduction
On 16 October 2026, the Minister of Health of the Republic of Indonesia issued Minister of Health Decree of the Republic of Indonesia No. HK.01.07/MENKES/1197/2026 on Guidelines for the Distribution and Supply of Over-the-Counter and Limited Over-the-Counter Medicines in Hypermarkets, Supermarkets, and Minimarkets (“Decree 1197/2026”). This Decree aims to provide guidelines for the government and licensed modern retail business operators in procuring, distributing, and supplying over-the-counter and limited over-the-counter medicines to consumers safely and in accordance with quality standards. Decree 1197/2026 also replaces Minister of Health Decree No. HK.01.07/Menkes/972/2025 (“Decree 972/2025”).
The issuance of Decree 1197/2026 was motivated by the need to expand public access to readily available and affordable over-the-counter and limited over-the-counter medicines, without compromising their safety, efficacy, and quality. In addition, this Decree was issued to align the previous regulations with legal requirements and to implement the provisions of Article 68 paragraph (4) of Minister of Health Regulation No. 5 of 2026 on Medical Supplies. These Guidelines also refer to Government Regulation No. 28 of 2024, which stipulates that pharmaceutical preparations may only be supplied by pharmaceutical service facilities and other licensed facilities, including hypermarkets, supermarkets, and minimarkets, as referred to in the Elucidation of Article 417 paragraph (1).
Comparison
Decree 1197/2026 revokes and declares Decree 972/2025 no longer applicable (DICTUM EIGHTH), with the following principal changes:
Aspect | Decree 1197/2026 | Decree 972/2025 |
Sources of supply for outlets without distribution centers | Outlets may obtain medicines through Pharmacies or Drugstores, which source the medicines from pharmaceutical manufacturers, Pharmaceutical Wholesalers (PBF), and/or PBF Branches (DICTUM FOURTH; Appendix C.1.b point 1). | Outlets may only obtain medicines through Drugstores (Appendix C.1.b point 1). |
Sources of medicines for branch distribution centers | Branch DCs may obtain medicines from pharmaceutical manufacturers, PBFs, PBF Branches, and their internal network DCs (Appendix C.1.a point 4 letter c). | Branch DCs may only obtain medicines from their internal network DCs (Appendix C.1.a point 4 letter c). |
Ordering procedures for outlets without distribution centers | There are two procedures:
| Drugstores receive medicine requests from outlets, which must be signed by the Health Support or Auxiliary Personnel responsible for the outlet. The upstream ordering procedure from the Drugstore is not regulated (Appendix C.1.b point 4). |
Minimum contents of cooperation agreements | The agreement must contain four matters: 1. Rights and obligations. 2. Supervision of medicine management at outlets by pharmaceutical personnel. 3. Reporting on medicine management at least once every 3 months. 4. Payment for medicine supply and supervisory services (Appendix C.1.b point 6). | The agreement must contain four matters: 1. Rights and obligations. 2. Supervision mechanisms and the responsibility of the Drugstore's pharmaceutical personnel for supplying medicines. 3. Reporting on medicine supply without a specified frequency. 4. Payment for medicine requests (Appendix C.1.b point 2). |
Medicines subject to minimum purchaser age requirements | Limited over-the-counter medicines containing pharmaceutical precursors and/or dextromethorphan may only be supplied to purchasers aged at least 18 years who present identification (Appendix C.2 letter c). | The minimum age requirement of 18 years, supported by identification, applies only to limited over-the-counter medicines containing pharmaceutical precursors (Appendix C.2 letter c). |
Prohibition on selling prescription medicines, narcotics, and psychotropic substances | No longer expressly listed as a prohibited activity. The provisions governing the supply of medicines consist only of letters a–g, although the scope of the Guidelines remains limited to over-the-counter and limited over-the-counter medicines. | Expressly listed as a prohibition (Appendix C.2 letter h). |
Personnel supplying medicines and their qualifications | Medicines must be supplied by Health Support or Auxiliary Personnel (DICTUM SIXTH). Preference is given to personnel with an educational background in pharmacy. Outlet owners must facilitate training on medicine management conducted by the Ministry of Health or an accredited institution. Personnel must hold certificates (Appendix C.3; DICTUM SEVENTH). | No specific dictum concerning personnel. Outlet owners must facilitate training, workshops, and/or other forms of training concerning the supply of medicines. There is no certification requirement or educational preference (Appendix C.3). |
Supervision by pharmaceutical personnel | Regulated in a separate section. Supervision applies to outlets operating through both the DC channel and the Pharmacy/Drugstore channel. Activities include reviewing each purchase order and reviewing records and conducting evaluations at least once every 3 months. Supervision results must be recorded and reported to the Ministry of Health, Provincial Health Offices, Regency/City Health Offices, and the relevant BPOM Technical Implementation Unit (UPT BPOM) (Appendix C.4). | No separate section. Supervision is only mentioned as a component of the cooperation agreement with the Drugstore, without details regarding activities, frequency, or reporting obligations. |
Key Provisions
Scope and Key Terms
Appendix Section B of Decree 1197/2026 establishes 14 definitions that form the basis for the implementation of these Guidelines. The regulatory scope covers over-the-counter and limited over-the-counter medicines, as well as three types of self-service retail stores classified according to their sales floor area, as follows:
Type of Self-Service Retail Store | Sales Floor Area |
Hypermarket | More than 5,000 m² |
Supermarket | More than 400 m² up to 5,000 m² |
Minimarket | Up to 400 m² |
In addition, several key terms that should be noted in implementing Decree 1197/2026 include:
Term | Definition |
Over-the-Counter Medicines | Medicines that are safe and may be supplied without a prescription to treat symptoms of minor illnesses. |
Limited Over-the-Counter Medicines | Prescription medicines that may be used for self-medication and supplied without a prescription in limited quantities, accompanied by warnings regarding their use. |
Distribution Center (“DC”) | A supporting facility of a self-service retail store used to store and distribute goods to outlets within its network. |
Health Support or Auxiliary Personnel | Any person who is neither medical personnel nor healthcare personnel but works to support healthcare efforts. |
Good Distribution Practice (CDOB) Certificate | Evidence that the procurement, storage, and distribution of medicines, including through electronic systems, have implemented Good Distribution Practice for Medicines. |
Two Channels for Medicine Supply
As stipulated in DICTUM FOURTH and Appendix C.1, retail outlets may only obtain over-the-counter and limited over-the-counter medicines through the following two channels:
Through a distribution center (DC) owned by the retail network itself, for outlets that have a DC; or
Through a partner Pharmacy or Drugstore, for outlets that do not have a DC.
Distribution Center Channel: Mandatory PBF Business Licence and CDOB Certification
DICTUM FIFTH and Appendix C.1.a point 2) require every DC distributing medicines to obtain two licences. First, a Pharmaceutical Wholesaler (PBF) business licence, by selecting the supporting business activity category in the Online Single Submission (OSS) system. Second, a business licence to support business activities in the form of a Good Distribution Practice for Medicines (CDOB) Certificate.
A DC that has obtained a PBF licence may establish branch DCs under a PBF Branch licence (point 3). In conducting distribution activities, Appendix C.1.a point 4) establishes the following requirements:
Distribution must comply with the business activity standards applicable to PBFs/PBF Branches and Good Distribution Practice for Medicines;
A DC may only purchase medicines from pharmaceutical manufacturers, PBFs, and PBF Branches. A branch DC may also receive medicines from DCs within its internal network;
Every medicine purchase by a DC must be based on a purchase order signed by the responsible Pharmacist, stating the Pharmacist's Registration Certificate (STR) number;
DCs and branch DCs may only distribute medicines to other DCs or outlets within their own internal network;
Distribution between DCs must use purchase orders signed by the responsible Pharmacist. Distribution to outlets must use purchase orders signed by the Health Support or Auxiliary Personnel at the relevant outlet; and
Branch DCs may only distribute medicines within the province covered by their licence. Distribution to directly adjacent provinces may only be conducted pursuant to an Assignment/Appointment Letter issued by the central DC. Such distribution plans must also be notified in writing to the Provincial Health Office of the destination province, with copies submitted to the Provincial Health Office of the originating province and the BPOM Technical Implementation Units (UPT BPOM) in both the originating and destination regions.
Furthermore, Appendix C.1.a point 5) requires DCs and branch DCs to report their network outlet lists annually and whenever necessary. Such reports must be submitted to the Ministry of Health, Provincial Health Offices, Regency/City Trade Offices, and the relevant local UPT BPOM.
Pharmacy or Drugstore Channel: Mandatory Cooperation Agreement
Appendix C.1.b of Decree 1197/2026 stipulates that outlets without a Distribution Center (“DC”) must obtain medicines through partner Pharmacies or Drugstores, which obtain their supplies from pharmaceutical manufacturers, Pharmaceutical Wholesalers (“PBF”), and/or PBF Branches. Medicine orders may be placed through the following two mechanisms:
Mechanism | Ordering Flow |
Request letter | Outlet → Pharmacy/Drugstore → Pharmaceutical Manufacturer/PBF/PBF Branch |
Retail quantities | Outlet → Pharmacy/Drugstore |
Cooperation Agreement and Obligations of the Parties
Every cooperation arrangement between an outlet and a Pharmacy or Drugstore must be formalised in a cooperation agreement containing, at a minimum, the following provisions:
Aspect | Requirements |
Rights and obligations | The respective rights and obligations of each party in relation to medicine supply. |
Supervision | Supervision of medicine management at the outlet by the pharmaceutical personnel of the Pharmacy or Drugstore. |
Reporting | Reporting on medicine management by the outlet to the responsible pharmaceutical personnel at least once every 3 (three) months or whenever necessary. |
Payment | Payment mechanism for medicine supply and the supervisory services provided by pharmaceutical personnel. |
In addition to these obligations, Decree 1197/2026 establishes two additional requirements for partner Pharmacies or Drugstores:
Cooperation limit: One Pharmacy or Drugstore may cooperate with a maximum of 5 (five) outlets within the same regency/city.
Reporting obligation: Pharmacies or Drugstores must submit a list of the outlets under their supervision annually and whenever necessary to the Regency/City Health Office, Regency/City Trade Office, and the relevant local UPT BPOM.
Rules Governing the Supply of Medicines to Consumers
DICTUM SIXTH of Decree 1197/2026 stipulates that medicines at outlets must be supplied by Health Support or Auxiliary Personnel. In implementing this requirement, Appendix C.2 establishes several provisions and prohibitions that outlets must comply with, as follows:
Aspect | Requirements |
Unit of supply | Medicines may only be supplied in their smallest packaging units, with the information as stated on the packaging. |
Quantity supplied | The quantity of medicines supplied must not exceed the amount required for 3 (three) days. |
Minimum age of purchasers | Limited over-the-counter medicines containing pharmaceutical precursors and/or dextromethorphan may only be supplied to purchasers who are at least 18 (eighteen) years old and present personal identification. |
Compounding and repackaging | Outlets are prohibited from compounding or repackaging medicines. |
Distribution to other facilities | Outlets are prohibited from distributing or supplying medicines to other facilities. |
Information on packaging | Outlets are prohibited from removing medicine information appearing on the smallest packaging unit. |
Condition and expiry date | Outlets are prohibited from supplying medicines that are damaged, whose safety, efficacy, and quality cannot be guaranteed, or whose remaining shelf life is less than 3 (three) months. |
Qualifications and Certification of Outlet Personnel
Appendix C.3 stipulates that personnel responsible for medicine management at outlets should preferably have an educational background in pharmacy. Outlet owners must facilitate their personnel's participation in training, workshops, and/or other forms of training concerning the management of over-the-counter and limited over-the-counter medicines. Such activities must be organised by the Ministry of Health or an accredited training institution. Personnel must hold certificates evidencing completion of such training.
Supervision by Pharmaceutical Personnel
Appendix C.4 places the management of medicines at each outlet under the supervision of pharmaceutical personnel. For outlets with a DC, supervision must be conducted by the pharmaceutical personnel of the DC or branch DC. For outlets without a DC, supervision must be conducted by the pharmaceutical personnel of the partner Pharmacy or Drugstore. Such supervision must, at a minimum, include:
Reviewing the reasonableness of each purchase order submitted by the outlet;
Reviewing records of medicine receipts and disbursements at the outlet at least once every 3 months or whenever necessary; and
Evaluating medicine management at the outlet at least once every 3 months or whenever necessary.
The pharmaceutical personnel concerned must record all supervision activities conducted. Such records must be reported to the Ministry of Health, Provincial Health Offices, Regency/City Health Offices, and the relevant local UPT BPOM. Pharmaceutical personnel may also participate in similar training organised by the Ministry of Health or an accredited institution.
Transitional Provisions
Decree 1197/2026 provides an adjustment period of no more than 1 (one) year from the date of its issuance, namely until 16 October 2027, for compliance with the following two principal obligations:
First, every retail network that has a Distribution Center (“DC”) must complete its Pharmaceutical Wholesaler (“PBF”) business licensing requirements and obtain a Good Distribution Practice for Medicines (“CDOB”) Certificate.
Second, every staff member responsible for supplying medicines at an outlet must undergo training, workshops, and/or other forms of training, as evidenced by a certificate.
Closing
Decree 1197/2026 clarifies the governance of the distribution and supply of over-the-counter and limited over-the-counter medicines in hypermarkets, supermarkets, and minimarkets, covering the entire process from procurement mechanisms and DC licensing requirements to cooperation arrangements with Pharmacies or Drugstores and the supply of medicines to consumers. This regulatory framework expands public access to medicines through modern retail outlets while strengthening oversight through the involvement of pharmaceutical personnel and periodic reporting obligations.
For modern retail business operators, implementing Decree 1197/2026 requires adjustments to medicine procurement and management mechanisms, fulfilment of DC licensing requirements, preparation of cooperation agreements with Pharmacies or Drugstores, and compliance with training requirements for outlet personnel. Although an adjustment period until 16 October 2027 is provided for fulfilment of the PBF/CDOB licensing requirements and personnel certification, all other obligations have been effective since 16 October 2026. Accordingly, business operators should promptly evaluate and adjust their operational practices to ensure compliance with Decree 1197/2026 and minimise the risk of non-compliance in their medicine distribution and supply activities.
Learn More Than Just Articles with
Learning
Get more practical material through ready-to-use templates, webinar recordings, compliance checklists, and online classes from Veritask Learning.
Templates
A collection of ready-to-use standard legal documents for a range of business needs.
Webinar Recording
Access recordings of in-depth discussions with experienced legal practitioners.
Online Class
Structured classes to master specific legal topics comprehensively.
Compliance
Practical checklists to keep your business compliant with regulations.
Log in to comment
Log inWhat is
Veritask is an integrated AI-powered legal platform that helps with regulatory research, document preparation, and compliance management in one dashboard.

Free Subscription
Subscribe to receive a free weekly email with the latest legal analysis.
